Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Love

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Colorado Nurse (1985)|February 5, 2015
Screening and brief interventionHolen Hirsh, Emily Love, Carolyn Swenson
Orphanet Journal of Rare Diseases|June 10, 2021
Development and content validity of the Barth Syndrome Symptom Assessment (BTHS-SA) for adolescents and adultsChad Gwaltney, Jonathan Stokes, Anthony Aiudi, et al.
BMC Palliative Care|July 2, 2025
The impacts of visitor restrictions for palliative patients during the COVID-19 pandemic on family members and healthcare providers: a Canadian qualitative studyNatasha Hanson, Leanne Skerry, Morgan Nesbitt, et al.
Journal of Clinical Neuromuscular Disease|November 20, 2020
Development of a Patient-Reported Outcome Questionnaire to Evaluate Primary Mitochondrial Myopathy Symptoms: The Primary Mitochondrial Myopathy Symptom AssessmentChad Gwaltney, Jonathan Stokes, Anthony Aiudi, et al.
Orphanet Journal of Rare Diseases|November 9, 2019
Understanding the life experience of Barth syndrome from the perspective of adults: a qualitative one-on-one interview studyIyar Mazar, Jonathan Stokes, Sarah Ollis, et al.
Orphanet Journal of Rare Diseases|April 25, 2025
Initial Psychometric Evaluation of the Barth Syndrome Symptom Assessment (BTHS-SA) for Adolescents and Adults in a Phase 2 Clinical StudyChad Gwaltney, Alan Shields, Emily Love, et al.
The Patient|January 21, 2020
Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and AdultsDiane M Turner-Bowker, Andrew Yaworsky, Andrew Palladino, et al.
Journal of Patient-Reported Outcomes|December 23, 2022
Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial diseaseChad Gwaltney, Jonathan Stokes, Anthony Aiudi, et al.
The British Journal of Dermatology|January 10, 2025
Development of novel patient-reported outcome instruments to assess atopic dermatitis-associated dyspigmentation and xerosis in patients with skin of colourChristopher Hartford, Andrew Alexis, Zhixiao Wang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Colorado Nurse (1985)|February 5, 2015
Screening and brief interventionHolen Hirsh, Emily Love, Carolyn Swenson
Orphanet Journal of Rare Diseases|June 10, 2021
Development and content validity of the Barth Syndrome Symptom Assessment (BTHS-SA) for adolescents and adultsChad Gwaltney, Jonathan Stokes, Anthony Aiudi, et al.
BMC Palliative Care|July 2, 2025
The impacts of visitor restrictions for palliative patients during the COVID-19 pandemic on family members and healthcare providers: a Canadian qualitative studyNatasha Hanson, Leanne Skerry, Morgan Nesbitt, et al.
Journal of Clinical Neuromuscular Disease|November 20, 2020
Development of a Patient-Reported Outcome Questionnaire to Evaluate Primary Mitochondrial Myopathy Symptoms: The Primary Mitochondrial Myopathy Symptom AssessmentChad Gwaltney, Jonathan Stokes, Anthony Aiudi, et al.
Orphanet Journal of Rare Diseases|November 9, 2019
Understanding the life experience of Barth syndrome from the perspective of adults: a qualitative one-on-one interview studyIyar Mazar, Jonathan Stokes, Sarah Ollis, et al.
Orphanet Journal of Rare Diseases|April 25, 2025
Initial Psychometric Evaluation of the Barth Syndrome Symptom Assessment (BTHS-SA) for Adolescents and Adults in a Phase 2 Clinical StudyChad Gwaltney, Alan Shields, Emily Love, et al.
The Patient|January 21, 2020
Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and AdultsDiane M Turner-Bowker, Andrew Yaworsky, Andrew Palladino, et al.
Journal of Patient-Reported Outcomes|December 23, 2022
Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial diseaseChad Gwaltney, Jonathan Stokes, Anthony Aiudi, et al.
The British Journal of Dermatology|January 10, 2025
Development of novel patient-reported outcome instruments to assess atopic dermatitis-associated dyspigmentation and xerosis in patients with skin of colourChristopher Hartford, Andrew Alexis, Zhixiao Wang, et al.
Pageof 1